The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

C•••••••• I••

Pharmaceuticalsgroup grade Aon a schedule nowsponsor C••••••• D••••••• • R•••• L•• inferred
Also written as: Health Care; Inc. First and

What matters now

  1. 96¢ → 101¢
    consensus mark

    Consensus mark 101¢ on cost, up from 96¢ a year ago, 101¢ last quarter.

    Q2 2026 · The lenders' own valuations moved back up.

    Derived7 of 7 lenders' own marks, weighted by principal
Mark path, consensus per quarter end
Q2 2025: 96¢Q3 2025: 95¢Q4 2025: 98¢Q1 2026: 101¢Q2 2026: 101¢96¢ · 95¢ · 98¢ · 101¢ · 101¢Q2 2025 to Q2 2026
Where each lender marks it, 6 points apart
97¢Consensus: 101¢B••• O•• C••••• I••••• C••••: 101¢B••• O•• T••••••••• F•••••• C••••: 102¢B••• O•• C•••••• C•••: 103¢B••• O•• T••••••••• I••••• C••••: 101¢S•••• P•••• C••••• C•••: 100¢S•••• P•••• C••••• I••••• F•••: 99¢G•••••• S•••• P•••••• C••••• C••••: 97¢103¢
Principal held
at least $338M
sum of BDC pieces, a lower bound
Fair value
$337M
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
13
7 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Oct 1, 2029
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
View all 7 lenderslargest exposure first
Every BDC piece · 8 positions across 7 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
B••• O•• C••••• I••••• C••••term loan second lien
S••••• lien senior secured loan | N••••••••• I•••••
$160M$160M
101c
S+925 bp
B••• O•• T••••••••• F•••••• C••••term loan second lien
S••••• lien senior secured loan | N••••••••• I•••••
$75.0M$75.0M
102c
S+925 bp
B••• O•• C••••• I••••• C••••term loan first lien
F•••• lien senior secured loan | N••••••••• I•••••
$34.8M$33.6M
99c
S+500 bp
B••• O•• C•••••• C•••term loan second lien
S••••• lien senior secured loan | N•••••••••
$30.0M$30.0M
103c
S+925 bp
B••• O•• T••••••••• I••••• C••••term loan second lien
S••••• lien senior secured loan
$25.0M$25.0M
101c
S+925 bp
View all 8 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
S•••• P•••• C••••• C•••term loan first lien
F•••• L••• T••• L•••, Due 10/12/2029
$8.1M$7.9M
100c
SOFR+500 bp
S•••• P•••• C••••• I••••• F•••term loan first lien
F•••• L••• T••• L•••
$3.0M$2.9M
99c
S+500 bp
G•••••• S•••• P•••••• C••••• C••••term loan first lien
1st L•••/S••••• S•••••• D••• I••••••• P••••••••• I••••••• R••• 8.73% R•••••••• R••• and S•
$2.5M$2.4M
97c
SOFR+500 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
second lien term loan second lienat least $290M102cS+925 bpOct 1, 20307
first lien term loan first lienat least $48.4M99cSOFR+500 bpOct 13, 20297
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20267$338M$337M101c0
Mar 31, 20267$338M$336M101c0
Dec 31, 20257$341M$328M98c0
Sep 30, 20257$339M$314M95c0
All 16 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20257$339M$318M96c0
Mar 31, 20257$339M$329M99c0
Dec 31, 20246$503M$489M99c0
Sep 30, 20248$337M$321M97c0
Jun 30, 20249$349M$341M100c0
Mar 31, 202410$348M$348M102c0
Dec 31, 202310$358M$357M102c0
Sep 30, 20239$351M$349M102c0
Jun 30, 20237$327M$314M99c0
Mar 31, 20237$324M$316M100c0
Dec 31, 20225$223M$217M100c0
Sep 30, 20222$28.3M$26.5M100c0
What changed
Full timeline · 19 events
Every change including routine ones
Identity
Group key
COVETRUSderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 13 BDCsderived
Industry
Pharmaceuticalsreportedas one filer wrote it